BiomX Inc. financial data

Symbol
PHGE on NYSE
Location
Ness Ziona, Israel
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 260% % -23%
Return On Equity -191% % -223%
Return On Assets -98% % -560%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 29,006,165 shares 60%
Common Stock, Shares, Outstanding 26,800,980 shares 47%
Entity Public Float $21,392,018 USD 29%
Common Stock, Value, Issued $7,000 USD 17%
Weighted Average Number of Shares Outstanding, Basic 31,399,552 shares 92%
Weighted Average Number of Shares Outstanding, Diluted 31,399,552 shares 92%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $22,768,000 USD 8.6%
General and Administrative Expense $10,359,000 USD -8.8%
Operating Income (Loss) $40,410,000 USD -22%
Nonoperating Income (Expense) $84,000 USD -75%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $37,366,000 USD -330%
Income Tax Expense (Benefit) $3,000 USD
Net Income (Loss) Attributable to Parent $37,375,000 USD -329%
Earnings Per Share, Basic 0 USD/shares -101%
Earnings Per Share, Diluted 1 USD/shares -85%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $6,923,000 USD -71%
Other Assets, Current $954,000 USD -74%
Assets, Current $8,862,000 USD -69%
Property, Plant and Equipment, Net $3,004,000 USD -54%
Operating Lease, Right-of-Use Asset $2,091,000 USD -78%
Goodwill $801,000 USD
Other Assets, Noncurrent $96,000 USD
Assets $26,168,000 USD -56%
Liabilities, Current $5,226,000 USD -42%
Contract with Customer, Liability, Noncurrent $1,976,000 USD 0%
Operating Lease, Liability, Noncurrent $5,287,000 USD -39%
Other Liabilities, Noncurrent $34,000 USD -79%
Retained Earnings (Accumulated Deficit) $203,559,000 USD -22%
Stockholders' Equity Attributable to Parent $10,486,000 USD -72%
Liabilities and Equity $26,168,000 USD -56%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $8,712,000 USD 23%
Net Cash Provided by (Used in) Financing Activities $11,913,000 USD -69%
Net Cash Provided by (Used in) Investing Activities $51,000 USD -92%
Common Stock, Shares Authorized 750,000,000 shares 0%
Common Stock, Shares, Issued 26,800,980 shares 47%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8,069,000 USD -67%
Interest Paid, Excluding Capitalized Interest, Operating Activities $5,000 USD -100%
Deferred Tax Assets, Valuation Allowance $48,841,000 USD 52%
Deferred Tax Assets, Gross $55,576,000 USD 68%
Operating Lease, Liability $9,584,000 USD 145%
Depreciation $236,000 USD 3.1%
Lessee, Operating Lease, Liability, to be Paid $12,538,000 USD 164%
Property, Plant and Equipment, Gross $10,544,000 USD 43%
Operating Lease, Liability, Current $1,296,000 USD 18%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,983,000 USD 188%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,952,000 USD 184%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,954,000 USD 246%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,015,000 USD 193%
Deferred Tax Assets, Operating Loss Carryforwards $42,454,000 USD 46%
Preferred Stock, Shares Issued 147,512 shares -0.15%
Preferred Stock, Shares Authorized 1,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $5,048,000 USD 634%
Operating Lease, Payments $134,000 USD
Additional Paid in Capital $195,421,000 USD 5.4%
Preferred Stock, Shares Outstanding 147,512 shares -0.15%
Share-based Payment Arrangement, Expense $2,558,000 USD -47%
Interest Expense $2,689,000 USD 24%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%